Impact of dosing strategy on clinical outcomes of patients with lupus nephritis initially treated with lower-than-recommended-dose cyclophosphamide

Kittiphan Chienwichai, Aniwat Choomnirat, Sorawat Sangkaew, Nutthapong Sunanthamethee, Arunchai Chang

Open source

DOI
10.1016/j.heliyon.2024.e37359
Published
2024-09
Container
Heliyon
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.heliyon.2024.e37359,
  title = {Impact of dosing strategy on clinical outcomes of patients with lupus nephritis initially treated with lower-than-recommended-dose cyclophosphamide},
  author = {Kittiphan Chienwichai and Aniwat Choomnirat and Sorawat Sangkaew and Nutthapong Sunanthamethee and Arunchai Chang},
  year = {2024},
  journal = {Heliyon},
  doi = {10.1016/j.heliyon.2024.e37359},
  url = {https://doi.org/10.1016/j.heliyon.2024.e37359}
}

RIS

TY  - JOUR
TI  - Impact of dosing strategy on clinical outcomes of patients with lupus nephritis initially treated with lower-than-recommended-dose cyclophosphamide
AU  - Kittiphan Chienwichai
AU  - Aniwat Choomnirat
AU  - Sorawat Sangkaew
AU  - Nutthapong Sunanthamethee
AU  - Arunchai Chang
PY  - 2024
JO  - Heliyon
DO  - 10.1016/j.heliyon.2024.e37359
UR  - https://doi.org/10.1016/j.heliyon.2024.e37359
ER  - 

APA

Chienwichai, K., Choomnirat, A., Sangkaew, S., Sunanthamethee, N., & Chang, A. (2024). Impact of dosing strategy on clinical outcomes of patients with lupus nephritis initially treated with lower-than-recommended-dose cyclophosphamide. Heliyon. https://doi.org/10.1016/j.heliyon.2024.e37359

Source records